Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo

NCT01766609 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: Triamcinolone Acetonide

Sponsor

University of British Columbia